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Identity 
Other names: CD135; FLK2 (Fetal liver kinase 2); 




The FLT3 gene contains 24 exons and spans at least 96 
kb of DNA; the exact size of the gene is unknown 
because there is a large intron (>50 kb) between exo 2 
and exon 3. 
Transcription 
3.7 kb; 2979 bp open reading frame. 
Protein 
Description 
993 amino acids; FLT3 is a class III receptor tyrosine 
kinase (RTK) structurally related to the receptors for 
platelet derived growth factor (PDGF), colony 
stimulating factor 1 (CSF1), and KIT ligand (KL); 
these RTK contain five immunoglobulin-like domains 
in the extracellular region and an intracelular tyrosine 
kinase domain split in two by a specific hydrophilic 
insertion (kinase insert); immunoprecipitation of the 
human FLT3 protein results in the appearance of a 
minor band of Mr 130 000 and a major band of Mr 155
000/160 000; the high-molecular-weight band 
corresponds to the mature, N-glycosylated form, and
the low-molecular-weight band to the immature, high 
mannose-containing form; N-linked glycosylations 
account for 50 000 daltons. 
Expression 
FLT3 expression was described on bone marrow 
CD34-positive cells, corresponding to multipotential, 
myeloid and B-lymphoid progenitor cells, and on 
monocytic cells; FLT3 expression is restricted to cells 
of the fetal liver expressing high levels of CD34; in 
addition, the FLT3 protein is expressed on blast cells 
from most ANLL and B-ALL. 
Localisation 
Functional mature form is at the plasma membrane. 
Function 
FLT3 receptor function can be defined by the activity 
of its ligand (FL); FL is an early acting factor and 
supports the survival, proliferation and differentiation 
of primitive hemopoietic progenitor cells. 
Mutations 
Somatic 
An internal tandem duplication in the juxtamembrane 
domain-coding sequence of the gene was found in 20% 
of acute non lymphocytic leukemias (ANLL) and in a 
small number of myelodysplasia; the duplicated 
sequence belongs to exon 11 but sometimes involves 
intron 11 and exon 12; these FLT3 gene mutations are 
significantly associated with leukocytosis in M1 and 
M2 but not in M4/5 ANLL, and are associated with an 
unfavorable prognosis regardless of the FAB subtype. 
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